Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting; a Randomised, Placebo-controlled Prophylaxis Study (COPCOV)

NCT04303507 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT04303507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04303507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting; a Randomised, Placebo-controlled Prophylaxis Study (COPCOV)
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Completed
Start date
April 29, 2020
Completion date
March 22, 2022
Enrollment
4,652 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory illnesses, coronavirus, covid19